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Myocardial perfusion reserve is impaired in aortic stenosis (AS) even in the absence of 
epicardial coronary stenosis (1), which may be due to reduced capillary density and
endothelial dysfunction (2,3). However, the relationship between histopathological 
abnormalities of the vasculature and myocardial perfusion reserve on CMR has never been 
examined in severe AS.  Understanding the pathophysiological mechanisms is important for 
advancing therapeutic strategies in AS - treatments that could potentially improve endothelial 
function may be beneficial in delaying the onset of symptoms in asymptomatic AS, or for 
symptomatic patients who are not candidates for aortic valve intervention. We sought to
characterise microvascular abnormalities in the myocardium of patients with severe AS and 
examine their relationship with myocardial perfusion reserve as assessed by stress perfusion 
cardiovascular magnetic resonance (CMR). 
Fourteen patients (mean age 71±7, 79% male) with normal coronary angiogram, scheduled 
for aortic valve replacement (AVR) were recruited. Patients with left ventricular (LV) 
ejection fraction <50%, uncontrolled hypertension, contraindications to CMR, significant 
coronary artery disease and underlying cardiomyopathy were excluded. Heart samples from 
nine age- and sex- matched subjects who suffered from non-cardiac deaths served as controls. 
The hearts were macroscopically and microscopically normal as assessed by an expert 
cardiac pathologist. AS patients underwent CMR scanning for cardiac function, mass, 
adenosine stress perfusion (n=12, 2 patients did not tolerate adenosine) and late gadolinium 
enhancement (LGE). Ten patients had a follow-up CMR scan 6 months post AVR. 
Myocardial biopsies were obtained from the basal anteroseptum during AVR. Control tissues 
were obtained from identical locations. Two consecutive sections were stained with smooth 
muscle actin (SMA) antibody and anti-CD31 for endothelium. CD31 and SMA antibodies 
stained images were quantified over an average of 10 power fields. Additionally, qualitative 
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assessment of presence of both SMA+ve and CD31+ve were undertaken for the same section 
of tissue.  
As expected, AS patients (all tricuspid aortic valve) had concentric LV hypertrophy with 
increased LV mass index. There was high prevalence of myocardial fibrosis (n=12, 86%) on 
qualitative LGE assessment. When compared to controls, severe AS had reduced myocardial 
vessel count as shown by reduced total quantity of SMA+ve vessels (AS: 135±75/mm2 vs 
control 386±155/mm2, p<0.001) and CD31+ve (AS: 500±251/mm2 vs control: 786±236/mm2, 
p=0.01), Figure 1. On qualitative assessment, there was marked loss of endothelial cells 
(absence of CD31+ve) but intact smooth muscle (SMA+ve), lining the arterioles in severe AS 
when compared to controls. P 2 (n=6) had 
greater endothe 2 (n=8); (AVA 
>0.8: 1.23±0.40% vs 2.77±1.11% AVA >0.8 2, p=0.007). The total area of 
CD31+ve endothelium correlated with AVA (r=0.58, p=0.03). In the 12 patients who 
underwent adenosine stress perfusion, mean myocardial perfusion reserve index (MPRI) was 
0.88±0.24. This was less than two standard deviations from our previously published normal 
MPRI range (1.7±0.3) from healthy volunteers of similar age and gender (1), indicating 
severe impairment in myocardial perfusion reserve in the AS patients enrolled in this study.
Endothelial loss and not vascular density also correlated with reduced MPRI, r=0.66, p=0.019
(Figure 1), which improved significantly post AVR (from 0.95±0.17 to 1.50±0.43, p=0.018).  
In this study, we have shown that the myocardium of patients with severe AS is not only 
characterised by capillary rarefaction but also endothelial cell loss. The extent of endothelial 
cell loss was associated with increasing severity of AS. Vascular endothelial loss, and not 
capillary rarefaction, correlated best with myocardial perfusion reserve.  
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The vascular endothelium plays an important homeostatic role in maintaining vasomotor tone 
by regulating both nitric oxide synthesis and release which in turn causes smooth muscle 
relaxation and vasodilation (4). Therefore, the loss of endothelium is likely to contribute to 
the impaired vasoreactivity and attenuated perfusion reserve seen in severe AS. Although 
myocardial biopsies post AVR were not available for a repeat histological assessment, 
myocardial perfusion reserve on CMR considerably improved post AVR. This suggests that 
the process of endothelial cell loss may be reversible and presents an opportunity for further 
research.  
Furthermore, although the onset of symptoms in severe AS is an indication for AVR, the 
detection of microvascular dysfunction could potentially help select individuals more likely 
to benefit from AVR as an alternative to the current symptom-based approach. In addition, 
given that AVR may be associated with operative risks, therapies that slow progression of 
disease or delay the onset of symptoms could be beneficial. Indeed, treatments found to be 
protect endothelial function, such as renin-angiotensin aldosterone system blockade, have 
been shown to slow the progression of AS (5). Future studies targeting the preservation of 
endothelial function, and in turn myocardial perfusion reserve, could therefore be important 
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Figure 1. A - Bar chart shows reduced number of vessels in aortic stenosis (AS) when 
compared to control (samples from non-cardiac death). B - Relationship between CD31+ve 
endothelium with myocardial perfusion reserve index (MPRI). C - Consecutive SMA and 
CD31 staining of myocardial samples. Red arrows show an example of high power 
magnification showing absence of CD31 staining in the same arteriole identified by SMA+ve 
indicating endothelial cell loss in AS.  













